Similar Articles
161 Immune effect and prognosis of transcatheter arterial chemoembolization and tyrosine kinase inhibitors therapy in patients with hepatocellular carcinoma
162 Clinical benefits of transarterial chemoembolization combined with tyrosine kinase and immune checkpoint inhibitors for unresectable hepatocellular carcinoma
163 Research trends and hotspots in the immune microenvironment related to hepatocellular carcinoma: A bibliometric and visualization study
164 Predicting hepatocellular carcinoma: A new non-invasive model based on shear wave elastography
165 Diagnostic and prognostic role of LINC01767 in hepatocellular carcinoma
166 Omics-imaging signature-based nomogram to predict the progression-free survival of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
167 Association between gut microbiota and hepatocellular carcinoma and biliary tract cancer: A mendelian randomization study
168 Predicting liver function after hemihepatectomy in patients with hepatocellular carcinoma using different modalities
169 Transarterial embolization is an acceptable bridging therapy to hepatocellular carcinoma prior to liver transplantation
170 Predicting the prognosis of hepatic arterial infusion chemotherapy in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA